| Study | Intermittent pathogen | Strategy 1 (new) probability | Strategy 2 (old) probability |
|---|---|---|---|
| Cohorts by pathogen | |||
| Federiksen 1999 | PA | 22.5% | 33.3% |
| France 2008 | BCC | 16.3% | 4.0% |
| Lee 2004 | PA | 34.5% (30%)a | 26.2% (28%)a |
| Whitford 1995b | BCC | 2.1% | 9.0% |
| Protective equipment | |||
| Chen 2001 | BCC | 0.9% | 8.8% |
| Savant 2014c | PA | 36% | 46% |
| Single inpatient room versus ward bed | |||
| Chen 2001 | BCC | 7.0% | 15.0% |
| France 2008 | BCC | 2.9% | 16.3% |
| Incomplete cohort segregation including en suite bathroom facilities versus no cohort segregation | |||
| Jones 2005d | PA | 0.0% | 9.7% |
BCC, B cepacia complex; PA, P aeruginosa
Prevalence data (incidence data) 1990 versus 2000
6 month probability translated into a 12 month probability using rates
Prevalence data as incidence data not calculable
2000 data compared to 2001 data as these are the dates when incidence is reported, the clinical evidence review compared 1999 to 2001 based on prevalence
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.